Market Research Logo

Finland Pharmaceuticals and Healthcare Report Q4 2017

Finland Pharmaceuticals and Healthcare Report Q4 2017

BMI View: Finland's pharmaceutical market is relatively small by Western European standards. We expectgrowth to slow in the coming years as high value medicine patents expire and the government continues topush competition and pricing policies, which favour cheaper generic drugs in an effort to containhealthcare spending. Nonetheless, Finland will remain a fairly attractive market for innovative drugmakersowing to an aging population and high per-capita spending coupled with its strong R&D infrastructure.

Headline Expenditure Projections

Pharmaceuticals: EUR3.09bn (USD3.42bn) in 2016 to EUR3.20bn (USD3.52bn) in 2017;+3.5% inlocal currency terms and +2.9% in US dollar terms. Forecast remains unchanged in local currency termsfrom last quarter.

Healthcare: EUR20.13bn (USD22.27bn) in 2016 to EUR20.83bn (USD22.91bn) in 2016; +3.4% in localcurrency terms and +2.9% in US dollar terms. Forecast in line with last quarter in local currency terms.

Risk/Reward Index

Western Europe is home to some of the most attractive pharmaceutical markets globally. However, despitethere being obvious rewards for companies looking to launch medicines in the region, it is vital thatcompanies appreciate the varying levels of both investment risk and reward that are present in the marketsin Western Europe. BMI's Innovative Pharmaceuticals Risk/Reward Index tool, which provides a globallycomparative and numerically based assessment of a market's attractiveness for companies looking to launcha high-value drug, was established to address this.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Finland 2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Finland 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Finland 2013-2021)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Finland 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Finland 2013-2021)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Finland 2013-2021)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Finland 2013-2021)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Finland 2013-2021)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Finland 2013-2021)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Finland 2015-2021)
Table: Pharmaceutical Trade Data And Forecasts local currency (Finland 2015-2021)
Industry Risk/Reward Index
Western Europe Pharmaceuticals: Large Market Sizes Boost Attractiveness
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Finland 2011-2016)
Table: Healthcare Personnel (Finland 2011-2016)
Table: Healthcare Activity (Finland 2011-2016)
Research And Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Table: PIF Members
Generic Drugmakers
Pharmaceutical Distribution & Retail Sector
Demographic Forecast
Finland Demographic Forecast
Table: Population Headline Indicators (Finland 1990-2025)
Table: Key Population Ratios (Finland 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Finland 1990-2025)
Table: Population By Age Group (Finland 1990-2025)
Table: Population By Age Group % (Finland 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report